Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $283

تينيت للرعاية الصحية

Tenet Healthcare Corporation

THC

0.00

Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE: THC) with a Buy and raises the price target from $242 to $283.